Akero Therapeutics Inc Stock
Price
Target price
€47.06
€47.06
-0.080%
-0.04
-0.080%
€68.61
20.11.25 / Tradegate
WKN: A2PLNP / Symbol: AKRO / Name: Akero Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Akero Therapeutics Inc Stock
There is nearly no change for the Akero Therapeutics Inc stock today. Compared to yesterday it only changed by -€0.040.
With 11 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 68 € there is a positive potential of 44.5% for Akero Therapeutics Inc compared to the current price of 47.06 €.
Our community identified positive and negative aspects for Akero Therapeutics Inc stock for the coming years. 2 users see the criterium "Revenue growth" as a plus for the Akero Therapeutics Inc stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Akero Therapeutics Inc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Akero Therapeutics Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc | -0.080% | 0.448% | 1.598% | 60.779% | 75.466% | 9.442% | - |
| Ardelyx Inc. | -0.910% | -4.087% | 9.915% | 2.953% | -3.102% | 139.353% | -1.696% |
| Krystal Biotech | -0.370% | 1.055% | 5.319% | 4.821% | 16.426% | 136.267% | - |
| Evolus Inc | -5.930% | -3.279% | 11.321% | -49.573% | -43.810% | -18.621% | 111.091% |
Comments
Akero Therapeutics (NASDAQ:AKRO) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Show more
Ratings data for AKRO provided by MarketBeat
Akero Therapeutics (NASDAQ:AKRO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $72.00 price target on the stock.
Show more
Ratings data for AKRO provided by MarketBeat
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at TD Cowen. They set a "buy" rating and a $76.00 price target on the stock.
Show more
Ratings data for AKRO provided by MarketBeat